| 摘要 |
The use of 1,3-di-n-butyl-7-(2-oxopropyl)xanthine for the manufactur of a medicament for the treatment of disorders resulting from a cerebral ischaemic event in mammals, comprising the administration of an effective, non-toxic, pharmaceutically acceptable amount of the compounds to the mammal in need thereof. |
